Despite having risk factors for heart disease, only 60 percent of women reported receiving counseling on optimizing their heart health at their six-week postpartum visits, according to a new Northwestern study.
Menu
Browsing: Clinical Breakthroughs
Pregnant people who report feeling unsafe in their neighborhoods are more likely to experience depression during pregnancy and have a baby with low birth weight, according to a study published in JAMA Network Open.
Metformin, a drug commonly used to treat diabetes, may prevent the development of “long COVID,” according to a clinical trial published in The Lancet Infectious Diseases.
A single infusion of CAR T-cell therapy induced complete response or remission in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, according to a recent clinical trial published in The Lancet.
Administering broad-spectrum antibiotics before surgery to remove pancreas tumors may decrease the chances of surgical site infection, according to a recent study published in JAMA.
New research from Northwestern investigators has demonstrated a method for engineering bone surfaces to improve the quality of bone grafts.
Adding a checkpoint inhibitor to conventional chemotherapy improved outcomes for patients with relapsed or refractory classic Hodgkin lymphoma, according to a Northwestern Medicine phase II clinical trial published in JAMA Oncology.
Fathers can make a significant difference in whether an infant is breastfed and placed to sleep safely, according to a recent survey of new fathers.
A new study has confirmed that circulatory death donor hearts that are reanimated and perfused with blood outside of the body are as safe and effective to transplant as brain death donor hearts preserved using traditional cold storage.
Northwestern Medicine investigators have developed a novel nanoparticle treatment for glioblastoma, according to a study published in Nature Communications.